| Income Statement |
| Operating Expenses | 25.50M |
|
| Research and Development Expense | 14.75M |
| Selling, General and Administrative Expense | 10.75M |
| Operating Income | -25.50M |
| Net Income | -24.22M |
| Net Income Common Stock | -24.22M |
| Net Income Common Stock (USD) | -24.22M |
| Consolidated Income | -24.22M |
| Earnings per Basic Share | -0.22 |
| Earnings per Basic Share (USD) | -0.22 |
| Earnings per Diluted Share | -0.22 |
| Earning Before Interest & Taxes (EBIT) | -24.22M |
| Earning Before Interest & Taxes (USD) | -24.22M |
| Weighted Average Shares | 112.22M |
| Weighted Average Shares Diluted | 112.22M |
| Balance Sheet |
| Cash and Equivalents | 225.59M |
| Cash and Equivalents (USD) | 225.59M |
| Current Assets | 227.00M |
| Property, Plant & Equipment Net | 125.00K |
| Total Assets | 228.64M |
| Current Liabilities | 11.75M |
| Total Liabilities | 11.75M |
| Accumulated Retained Earnings (Deficit) | -248.77M |
| Shareholders Equity | 216.90M |
| Shareholders Equity (USD) | 216.90M |
| Assets Non-Current | 1.64M |
| Trade and Non-Trade Payables | 11.75M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 16.00K |
| Net Cash Flow from Financing | 135.12M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 116.19M |
| Capital Expenditure | -13.00K |
| Issuance (Purchase) of Equity Shares | 135.12M |
| Net Cash Flow from Investing | -13.00K |
| Net Cash Flow from Operations | -18.92M |
| Share Based Compensation | 5.01M |